loading page

Pediatric Cancer Management during SARS-CoV-2: A Brief Communication of 28 Patients and Changes in Clinical Practice from a Single Leading Institute in Pakistan
  • +2
  • Mir Ibrahim Sajid,
  • Sadaf Altaf,
  • Naureen Mushtaq,
  • Asim Belgaumi,
  • Zehra Fadoo
Mir Ibrahim Sajid
Aga Khan University
Author Profile
Sadaf Altaf
Aga Khan University
Author Profile
Naureen Mushtaq
Aga Khan University
Author Profile
Asim Belgaumi
Aga Khan University
Author Profile
Zehra Fadoo
Aga Khan University
Author Profile

Abstract

All tested patients were classified into two groups, Group A (patients who were tested positive) and Group B (patients who were tested negative). A total of 28 patients were evaluated. The primary diagnosis of patients in Group A was B-Cell ALL and Thalassemia Major (50% each), whereas, in Group B, the primary diagnosis was B-Cell ALL (46.1%) and AML. The most prevalent symptoms warranting testing in Group A were fever (100%) and cough (50%); Group B the most common symptoms were fever (53.8%), cough (26.9%), and neutropenia (15.4%). No mortality or significant morbidity was reported in either of the cohorts.